Goldman Sachs Group Inc - Jun 30, 2025 SCHEDULE 13G/A Report for SYNDAX PHARMACEUTICALS, INC. Common Stock (SNDX)

Filing Manager: GOLDMAN SACHS GROUP INC
Reporting Manager: THE GOLDMAN SACHS GROUP, INC.
Security: SYNDAX PHARMACEUTICALS, INC. Common Stock
Symbol: SNDX
Shares outstanding: 85.9M shares
Disclosed Ownership: 5.58M shares
Ownership: 6.5%
Form type: SCHEDULE 13G/A
Date filed: 8/13/2025, 05:52 PM
Date of event: Jun 30, 2025
Previous filing: May 9, 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
THE GOLDMAN SACHS GROUP, INC.	6.5%	5.58M	0	5.58M	Name:	Attorney-in-fact
GOLDMAN SACHS & CO. LLC	6.5%	5.58M	0	5.58M	Name:	Attorney-in-fact